Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A structural modification study of procarbazine.

L T Weinstock, C C Cheng

    Journal of Medicinal Chemistry
    |May 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Researchers synthesized eight new procarbazine analogues for cancer treatment. Preliminary tests showed none of these novel compounds were as effective as procarbazine against L1210 and P388 leukemias.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Toll-like receptor signalling associated with immunomodulation of umbilical cord-derived mesenchymal stem cells in mice with systemic lupus erythematosus.

    Lupus·2020
    Same author

    Empirical Selection of Informative Microsatellite Markers within Co-ancestry Pig Populations Is Required for Improving the Individual Assignment Efficiency.

    Asian-Australasian journal of animal sciences·2014
    Same author

    Studies on 4-aminopyrazolo(3,4-d)pyrimidine: action of derivatives and analogues on hela cells.

    Antibiotics & chemotherapy (Northfield, Ill.)·2014
    Same author

    Toward an ideal animal model to trace donor cell fates after stem cell therapy: production of stably labeled multipotent mesenchymal stem cells from bone marrow of transgenic pigs harboring enhanced green fluorescence protein gene.

    Journal of animal science·2011
    Same author

    Form-birefringent computer-generated holograms.

    Optics letters·2009
    Same author

    Fabrication, modeling, and characterization of form-birefringent nanostructures.

    Optics letters·2009
    Same journal

    Small Molecules in Development for the Treatment of Sepsis: Insights into Drug Targets and Molecular Mechanisms.

    Journal of medicinal chemistry·2026
    Same journal

    Isofagomine Derivatives as TcdB Glucosyltransferase Inhibitors.

    Journal of medicinal chemistry·2026
    Same journal

    The One-Step Incorporation of Boron-10 Atom into Prostate Cancer-Targeted Fluorophores for Visualizing In Vivo Boron-10 Delivery and Intratumoral Distribution with Cellular Resolution.

    Journal of medicinal chemistry·2026
    Same journal

    Design and Evaluation of Conformationally Locked Indole-Carboxylic Acids as Selective THRβ Agonists against MASH.

    Journal of medicinal chemistry·2026
    Same journal

    Drug Screening of Nitroreductase Modulators Using an Atomic-Engineered Activatable Fluorescent Probe for Tumor Imaging.

    Journal of medicinal chemistry·2026
    Same journal

    Reprogramming Acetaminophen Metabolism via Amide-to-Thioamide Modification to Prevent Drug-Induced Liver Injury.

    Journal of medicinal chemistry·2026
    See all related articles

    Area of Science:

    • Medicinal Chemistry
    • Pharmacology
    • Oncology

    Background:

    • Procarbazine is an established antineoplastic agent used in cancer chemotherapy.
    • Structural modification of known drugs is a common strategy to discover more effective or less toxic therapeutic agents.

    Purpose of the Study:

    • To synthesize and evaluate novel analogues of procarbazine.
    • To investigate the structure-activity relationship of procarbazine analogues in leukemia models.

    Main Methods:

    • Eight analogues of procarbazine were synthesized.
    • Chemical modifications were focused on specific portions of the procarbazine molecule.
    • Analogues were screened for antineoplastic activity against L1210 and P388 leukemia cell lines.

    Related Experiment Videos

    Main Results:

    • All eight synthesized procarbazine analogues were evaluated.
    • None of the tested analogues demonstrated superior antineoplastic activity compared to the parent compound, procarbazine.
    • The screening was conducted using established leukemia models (L1210 and P388).

    Conclusions:

    • The synthesized procarbazine analogues did not exhibit enhanced efficacy over procarbazine in the tested leukemia models.
    • Further research may be needed to identify procarbazine modifications that improve antineoplastic activity.